1026 related articles for article (PubMed ID: 26000626)
1. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
Fairbrother G; Burigo J; Sharon T; Song K
J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
[TBL] [Abstract][Full Text] [Related]
2. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population.
Song K; Musci TJ; Caughey AB
J Matern Fetal Neonatal Med; 2013 Aug; 26(12):1180-5. PubMed ID: 23356557
[TBL] [Abstract][Full Text] [Related]
4. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
[TBL] [Abstract][Full Text] [Related]
5. An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population.
Benn P; Curnow KJ; Chapman S; Michalopoulos SN; Hornberger J; Rabinowitz M
PLoS One; 2015; 10(7):e0132313. PubMed ID: 26158465
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
9. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
[TBL] [Abstract][Full Text] [Related]
10. [Clinical implementation of non-invasive prenatal study for detecting aneuploidies by fetal DNA based on single nucleotide polymorphisms: two years in Mexico].
Sánchez-Usabiaga RA; Aguinaga-Ríos M; Batista-Espinoza A; Hurtado-Amador R; Romero-Tovar S
Ginecol Obstet Mex; 2015 Apr; 83(4):220-31. PubMed ID: 26727755
[TBL] [Abstract][Full Text] [Related]
11. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
Kagan KO; Eiben B; Kozlowski P
Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis.
Nshimyumukiza L; Beaumont JA; Duplantie J; Langlois S; Little J; Audibert F; McCabe C; Gekas J; Giguère Y; Gagné C; Reinharz D; Rousseau F
J Obstet Gynaecol Can; 2018 Jan; 40(1):48-60. PubMed ID: 28784564
[TBL] [Abstract][Full Text] [Related]
14. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
La Verde M; De Falco L; Torella A; Savarese G; Savarese P; Ruggiero R; Conte A; Fico V; Torella M; Fico A
BMC Med Genomics; 2021 Mar; 14(1):93. PubMed ID: 33785045
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis.
Zhang W; Mohammadi T; Sou J; Anis AH
PLoS One; 2019; 14(12):e0225281. PubMed ID: 31800591
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary analysis of the cause for the failure of non-invasive prenatal testing using cell-free fetal DNA derived from peripheral maternal blood].
Zhang B; Shen C; Wang H; Cai Z; Lu B; Zhang X; Yu B; Wang T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):329-333. PubMed ID: 29896725
[TBL] [Abstract][Full Text] [Related]
17. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
[TBL] [Abstract][Full Text] [Related]
18. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.
Li SW; Barrett AN; Gole L; Tan WC; Biswas A; Tan HK; Choolani M
Singapore Med J; 2015 Jan; 56(1):47-52. PubMed ID: 25640099
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Economic Impact of Adopting Noninvasive Prenatal Testing as a Primary Screening Method for Fetal Aneuploidies in the General Pregnancy Population.
Kostenko E; Chantraine F; Vandeweyer K; Schmid M; Lefevre A; Hertz D; Zelle L; Bartha JL; Di Renzo GC
Fetal Diagn Ther; 2019; 45(6):413-423. PubMed ID: 30130800
[TBL] [Abstract][Full Text] [Related]
20. Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System.
Gerundino F; Giachini C; Contini E; Benelli M; Marseglia G; Giuliani C; Marin F; Nannetti G; Lisi E; Sbernini F; Periti E; Cordisco A; Colosi E; D'ambrosio V; Mazzi M; Rossi M; Staderini L; Minuti B; Pelo E; Cicatiello R; Maruotti GM; Sglavo G; Conti A; Frusconi S; Pescucci C; Torricelli F
J Matern Fetal Neonatal Med; 2017 Mar; 30(6):710-716. PubMed ID: 27226231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
